Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Mixed dementia: emerging concepts and therapeutic implications.

Langa KM, Foster NL, Larson EB.

JAMA. 2004 Dec 15;292(23):2901-8. Review.

PMID:
15598922
2.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD003154.

PMID:
12917950
3.

Pharmacologic treatments of dementia.

Bonner LT, Peskind ER.

Med Clin North Am. 2002 May;86(3):657-74. Review.

PMID:
12171061
4.

Vascular cognitive impairment: disease mechanisms and therapeutic implications.

Levine DA, Langa KM.

Neurotherapeutics. 2011 Jul;8(3):361-73. doi: 10.1007/s13311-011-0047-z. Review.

5.

Memantine for dementia.

Areosa Sastre A, McShane R, Sherriff F.

Cochrane Database Syst Rev. 2004 Oct 18;(4):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(2):CD003154.

PMID:
15495043
6.

Use of antidementia agents in vascular dementia: beyond Alzheimer disease.

Farlow MR.

Mayo Clin Proc. 2006 Oct;81(10):1350-8. Review.

PMID:
17036561
7.

Management of mixed dementia.

Zekry D, Gold G.

Drugs Aging. 2010 Sep 1;27(9):715-28. doi: 10.2165/11538250-000000000-00000. Review.

PMID:
20809662
8.

Memantine for dementia.

Areosa SA, Sherriff F.

Cochrane Database Syst Rev. 2003;(1):CD003154. Review. Update in: Cochrane Database Syst Rev. 2003;(3):CD003154.

PMID:
12535459
9.

Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia.

Smith M, Wells J, Borrie M.

Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3):133-7. Review.

PMID:
16917181
10.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Apr 18;(2):CD003154. Review. Update in: Cochrane Database Syst Rev. 2005;(3):CD003154.

PMID:
15846650
11.

Memantine for dementia.

Areosa SA, Sherriff F, McShane R.

Cochrane Database Syst Rev. 2005 Jul 20;(3):CD003154. Review. Update in: Cochrane Database Syst Rev. 2006;(2):CD003154.

PMID:
16034889
12.

Memantine for dementia.

McShane R, Areosa Sastre A, Minakaran N.

Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003154. Review.

PMID:
16625572
13.

Memantine: pharmacological properties and clinical uses.

Kumar S.

Neurol India. 2004 Sep;52(3):307-9. Review.

14.

Pharmacologic rationale for memantine in chronic cerebral hypoperfusion, especially vascular dementia.

Möbius HJ.

Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S172-8. Review.

PMID:
10609698
15.

Diagnosis and management of vascular cognitive impairment and dementia.

Erkinjuntti T.

J Neural Transm Suppl. 2002;(63):91-109. Review.

PMID:
12597611
16.

Neuropathological evaluation of mixed dementia.

Jellinger KA, Attems J.

J Neurol Sci. 2007 Jun 15;257(1-2):80-7. Epub 2007 Feb 26. Review.

PMID:
17324442
17.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Review.

18.

Pharmacological prevention and treatment of vascular dementia: approaches and perspectives.

Baskys A, Cheng JX.

Exp Gerontol. 2012 Nov;47(11):887-91. doi: 10.1016/j.exger.2012.07.002. Epub 2012 Jul 13. Review.

PMID:
22796225
19.

Treatment of vascular dementia-evidence from clinical trials with cholinesterase inhibitors.

Erkinjuntti T, Román G, Gauthier S.

Neurol Res. 2004 Jul;26(5):603-5. Review.

PMID:
15265282
20.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119

Supplemental Content

Support Center